> ## Content Index
> Fetch the complete content index at: https://members.americanhealthintel.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# 9 more drugmakers join Trump's most-favored-nation pricing deal
- URL: https://members.americanhealthintel.com/2026-09-02-regulator/
- Published: 2026-09-02T10:05:56.000Z
- Updated: 2026-09-02T10:05:56.000Z
- Description: Plus: Federal deadline passed for Medicaid work-requirement notices. The day's rules, money, and enforcement, sourced and tiered below.
- Author: American Health Intel

Plus: Federal deadline passed for Medicaid work-requirement notices. The day's rules, money, and enforcement, sourced and tiered below.

| American Health Intel Rules · Money · Medicine · Decoded daily The Regulator Wednesday, September 2, 2026 9 more drugmakers join Trump's most-favored-nation pricing deal Plus: Federal deadline passed for Medicaid work-requirement notices. The day's rules, money, and enforcement, sourced and tiered below. ![](https://americanhealthintel.com/email/pulse-divider.png) Rule Confidence: High Nine more drugmakers, including generic and specialty manufacturers Teva, CSL and Sun Pharma, joined Trump's drug pricing program, pledging billions in US manufacturing for access to Medicaid markets nationwide. The nine manufacturers committed $19.6 billion combined to US manufacturing. The program now covers 26 drugmakers and 89% of the branded drug market, with most-favored-nation pricing extended to every state's Medicaid program. Why it matters This significantly widens a federal drug pricing program tying US prices to the lowest price paid in other wealthy countries. Watch whether the projected $600 billion in savings, an administration estimate rather than an independent one, actually materializes. Sources: [Hitehouse](https://www.whitehouse.gov/fact-sheets/2026/08/fact-sheet-president-donald-j-trump-announces-deal-with-nine-additional-pharmaceutical-manufacturers-to-lower-drug-prices-for-americans/?ref=members.americanhealthintel.com) · [Cnbc](https://www.cnbc.com/2026/08/31/trump-drug-pricing-deals.html?ref=members.americanhealthintel.com) Deadline Confidence: High A federal deadline passed for every state Medicaid program that expanded coverage under the Affordable Care Act: each had to warn enrollees that new work requirements could cost them coverage starting in 2027. In Washington state, where nearly 1.9 million people rely on the Apple Health Medicaid program, the Governor's office estimates roughly 250,000 residents could lose coverage as the new work rules and other changes phase in. Why it matters This signals a major coverage disruption coming in 2027 as work requirements take effect. Watch state-by-state enrollment and disenrollment data as implementation proceeds. Sources: [Federal Register](https://www.federalregister.gov/documents/2026/06/03/2026-11094/medicaid-program-community-engagement-requirement-for-certain-individuals?ref=members.americanhealthintel.com) · [Wa](https://governor.wa.gov/news/2025/governor-ferguson-calls-congress-abandon-harmful-legislation-threatens-health-care-access-nearly-2?ref=members.americanhealthintel.com) Also today Congress dodges shutdown, delays OMB federal grants rule [Read](https://americanhealthintel.com/editions/2026-09-02-regulator/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#congress-cr-omb-uniform-guidance-delay) HHS sends $77M for addiction and mental health on Overdose Awareness Day [Read](https://americanhealthintel.com/editions/2026-09-02-regulator/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#hhs-samhsa-77m-substance-use-mental-health-grants) New Medicare documentation rules for trigger point injections nationwide [Read](https://americanhealthintel.com/editions/2026-09-02-regulator/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#medicare-trigger-point-injections-lcd-national) 656Records$38.4BEnforcement28Deadlines175Rules [Read this issue + the trackers](https://americanhealthintel.com/editions/2026-09-02-regulator/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) Pick your field on the site and every story tells you what it means for you. Reply to this email and tell us what you want covered. We read everything. We show our work. We score our own calls. [Track record](https://americanhealthintel.com/ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Calendar](https://americanhealthintel.com/calendar/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Enforcement](https://americanhealthintel.com/enforcement/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [X](https://x.com/amhealthintel?ref=members.americanhealthintel.com) · [LinkedIn](https://www.linkedin.com/company/american-health-intel?ref=members.americanhealthintel.com) News and analysis, not legal, medical, coding, or investment advice.You subscribed at americanhealthintel.com · [Unsubscribe](%%{unsubscribe%5Furl}%%) |
| ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |